Related references
Note: Only part of the references are listed.Macrophages and fibroblasts during inflammation, tissue damage and organ injury
Trevor Glaros
Frontiers in Bioscience-Landmark (2009)
Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells
Padmaja Magadala et al.
AAPS JOURNAL (2008)
Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract
Mayank D. Bhavsar et al.
AAPS PHARMSCITECH (2008)
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Marie Morille et al.
BIOMATERIALS (2008)
Macrophage activation and polarization
Fernando Oneissi Martinez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease
M. D. Bhavsar et al.
GENE THERAPY (2008)
Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice
Aliasgar Shahiwala et al.
JOURNAL OF DRUG TARGETING (2008)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles
Dipti Deshpande et al.
PHARMACEUTICAL RESEARCH (2008)
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS)
Mayank D. Bhavsar et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Polymeric nano- and microparticle technologies for oral gene delivery
Mayank D. Bhavsar et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors
S. Kommareddy et al.
CANCER GENE THERAPY (2007)
Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery
Sushma Kommareddy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design
MD Bhavsar et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione
S Kommareddy et al.
BIOCONJUGATE CHEMISTRY (2005)
Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies
G Kaul et al.
PHARMACEUTICAL RESEARCH (2005)
Towards safe, non-viral therapeutic gene expression in humans
DJ Glover et al.
NATURE REVIEWS GENETICS (2005)
Gene therapy for autoimmune diseases:: Quo Vadis?
Y Chernajovsky et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery
G Kaul et al.
PHARMACEUTICAL RESEARCH (2002)
Gene delivery with synthetic (non viral) carriers
MD Brown et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)